BioCentury | Aug 15, 2019
Company News

Aug. 15 Company Quick Takes: IQVia's patient portal; plus Gilead/Galapagos and GeneCentric/Select ImmunoGenomics

...to FDA this year (see "Filgotinib Hits More RA Endpoints" ). GeneCentric acquires Select ImmunoGenomics GeneCentric Therapeutics Inc....
...development capabilities. Financial terms were undisclosed. Hongjiang Li and Elizabeth S. Eaton, Staff Writers filgotinib (GLPG0634, GS-6034) Galapagos N.V. GeneCentric Therapeutics Inc. Gilead...
BioCentury | Jan 5, 2019
Company News

Flurry of management moves on eve of JPM

...Yarra Therapeutics LLC, a rare disease subsidiary of Array Biopharma Inc. (NASDAQ:ARRY). Precision cancer company GeneCentric Therapeutics Inc....
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...Smith as president. He was president and COO of Celgene Corp. (NASDAQ:CELG). Precision cancer company GeneCentric Therapeutics Inc....
BioCentury | Jan 12, 2017
Company News

GeneCentric, Bristol-Myers Squibb deal

...will be primarily the lead on the deal. The companies declined to disclose further details. GeneCentric Diagnostics...
...Inc. , Durham, N.C. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Cancer Nora Weintraub Opdivo Bristol-Myers Squibb Co. GeneCentric Diagnostics...
BioCentury | Jul 28, 2014
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 2014-07-11 Type: Venture financing Raised: $5 million Note: The company raised $5 million, according to an SEC filing. WIR Staff Diagnostic...
BioCentury | Feb 11, 2013
Emerging Company Profile

GeneCentric: Cancer sign-off

...American Society of Clinical Oncology (ASCO), Alexandria, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GeneCentric Diagnostics...
BioCentury | Sep 3, 2012
Company News

GeneCentric Diagnostics, University of North Carolina deal

...final validation testing of the Lung Subtype Platform technology. The company declined to provide details. GeneCentric Diagnostics...
BioCentury | Jan 30, 2012
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 9/2/11 Type: Venture financing Raised: $250,000 Investor: Hatteras Venture Partners WIR Staff Diagnostic...
BioCentury | Jan 24, 2012
Financial News

GeneCentric Diagnostics debuts

...Molecular diagnostic company GeneCentric Diagnostics Inc. (Durham, N.C.) said it raised $250,000 from Hatteras Venture Partners last...
Items per page:
1 - 9 of 9
BioCentury | Aug 15, 2019
Company News

Aug. 15 Company Quick Takes: IQVia's patient portal; plus Gilead/Galapagos and GeneCentric/Select ImmunoGenomics

...to FDA this year (see "Filgotinib Hits More RA Endpoints" ). GeneCentric acquires Select ImmunoGenomics GeneCentric Therapeutics Inc....
...development capabilities. Financial terms were undisclosed. Hongjiang Li and Elizabeth S. Eaton, Staff Writers filgotinib (GLPG0634, GS-6034) Galapagos N.V. GeneCentric Therapeutics Inc. Gilead...
BioCentury | Jan 5, 2019
Company News

Flurry of management moves on eve of JPM

...Yarra Therapeutics LLC, a rare disease subsidiary of Array Biopharma Inc. (NASDAQ:ARRY). Precision cancer company GeneCentric Therapeutics Inc....
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...Smith as president. He was president and COO of Celgene Corp. (NASDAQ:CELG). Precision cancer company GeneCentric Therapeutics Inc....
BioCentury | Jan 12, 2017
Company News

GeneCentric, Bristol-Myers Squibb deal

...will be primarily the lead on the deal. The companies declined to disclose further details. GeneCentric Diagnostics...
...Inc. , Durham, N.C. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Cancer Nora Weintraub Opdivo Bristol-Myers Squibb Co. GeneCentric Diagnostics...
BioCentury | Jul 28, 2014
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 2014-07-11 Type: Venture financing Raised: $5 million Note: The company raised $5 million, according to an SEC filing. WIR Staff Diagnostic...
BioCentury | Feb 11, 2013
Emerging Company Profile

GeneCentric: Cancer sign-off

...American Society of Clinical Oncology (ASCO), Alexandria, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GeneCentric Diagnostics...
BioCentury | Sep 3, 2012
Company News

GeneCentric Diagnostics, University of North Carolina deal

...final validation testing of the Lung Subtype Platform technology. The company declined to provide details. GeneCentric Diagnostics...
BioCentury | Jan 30, 2012
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 9/2/11 Type: Venture financing Raised: $250,000 Investor: Hatteras Venture Partners WIR Staff Diagnostic...
BioCentury | Jan 24, 2012
Financial News

GeneCentric Diagnostics debuts

...Molecular diagnostic company GeneCentric Diagnostics Inc. (Durham, N.C.) said it raised $250,000 from Hatteras Venture Partners last...
Items per page:
1 - 9 of 9